In general terms, I consider tumors with ER and PR expression <10% as hormone receptor negative. Our analysis of outcomes for these patients at our institution suggest thy do just as well (or as poorly) as those with ER 0% and PR 0%. Therefore, I do not recommend the use of endocrine therapy of ...